{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T02:03:34Z","timestamp":1791165814665,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.jpba.2019.04.031","type":"journal-article","created":{"date-parts":[[2019,4,17]],"date-time":"2019-04-17T13:07:44Z","timestamp":1555506464000},"page":"175-182","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Quantification of the tyrosine kinase inhibitor erlotinib in human scalp hair by liquid chromatography-tandem mass spectrometry: Pitfalls for clinical application"],"prefix":"10.1016","volume":"172","author":[{"given":"C. Louwrens","family":"Braal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.D. Marijn","family":"Veerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Peric","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim G.J.V.","family":"Aerts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron H.J.","family":"Mathijssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stijn L.W.","family":"Koolen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"de Bruijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"March 166","key":"10.1016\/j.jpba.2019.04.031_bib0005","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jpba.2018.12.040","article-title":"LC-MS application for therapeutic drug monitoring in alternative matrices","volume":"20","author":"Avataneo","year":"2019","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"June 158","key":"10.1016\/j.jpba.2019.04.031_bib0010","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jpba.2018.05.052","volume":"1","author":"Reis","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"May (10)","key":"10.1016\/j.jpba.2019.04.031_bib0015","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1002\/elps.201300573","article-title":"Simultaneous determination of erlotinib and metabolites in human urine using capillary electrophoresis","volume":"35","author":"Rodr\u00edguez","year":"2014","journal-title":"Electrophoresis."},{"issue":"June(3)","key":"10.1016\/j.jpba.2019.04.031_bib0020","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1097\/FTD.0000000000000004","article-title":"Plasma concentrations of tyrosine kinase inhibitors imatinib, erlotinib, and sunitinib in routine clinical outpatient cancer care","volume":"36","author":"Lankheet","year":"2014","journal-title":"Ther. Drug Monit."},{"issue":"October 114","key":"10.1016\/j.jpba.2019.04.031_bib0025","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.jpba.2015.06.018","article-title":"Development and validation of an UPLC\u2013MS\/MS method for the quantification of tamoxifen and its main metabolites in human scalp hair","volume":"10","author":"Drooger","year":"2015","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"November (1)","key":"10.1016\/j.jpba.2019.04.031_bib0030","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.forsciint.2012.10.012","article-title":"Metabolite to parent drug concentration ratios in hair for the differentiation of tramadol intake from external contamination and passive exposure","volume":"223","author":"Madry","year":"2012","journal-title":"Forensic Sci. Int."},{"issue":"April (8)","key":"10.1016\/j.jpba.2019.04.031_bib0035","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/rcm.8077","article-title":"A validated liquid chromatography\/tandem mass spectrometry method for the analysis of efavirenz in 0.2 mg hair samples from human immunodeficiency virus infected patients","volume":"32","author":"Johnston","year":"2018","journal-title":"Rapid Commun Mass Spectrom RCM."},{"issue":"August","key":"10.1016\/j.jpba.2019.04.031_bib0040","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.pupt.2018.07.001","article-title":"Hair analysis to monitor adherence to prescribed chronic inhaler drug therapy in patients with asthma or COPD","volume":"51","author":"Hassall","year":"2018","journal-title":"Pulm. Pharmacol. Ther."},{"issue":"June (5)","key":"10.1016\/j.jpba.2019.04.031_bib0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jpba.2018.03.031","article-title":"A novel single-step GC-MS\/MS method for cannabinoids and 11-OH-THC metabolite analysis in hair","volume":"155","author":"Angeli","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"July 126","key":"10.1016\/j.jpba.2019.04.031_bib0050","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jpba.2016.04.015","article-title":"Hair testing in clinical setting: simultaneous determination of 50 psychoactive drugs and metabolites in headache patients by LC tandem MS","volume":"15","author":"Licata","year":"2016","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"January (1)","key":"10.1016\/j.jpba.2019.04.031_bib0055","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/jat\/bkx077","article-title":"Is Hair Analysis Useful in Postmortem Cases?","volume":"42","author":"H\u00f8iseth","year":"2018","journal-title":"J. Anal. Toxicol."},{"issue":"December (8)","key":"10.1016\/j.jpba.2019.04.031_bib0060","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/jat\/27.8.545","article-title":"The effect of hair color on the incorporation of codeine into human hair","volume":"27","author":"Rollins","year":"2003","journal-title":"J. Anal. Toxicol."},{"issue":"August (4)","key":"10.1016\/j.jpba.2019.04.031_bib0065","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/00007691-199608000-00022","article-title":"Mechanisms of drug incorporation into hair","volume":"18","author":"Cone","year":"1996","journal-title":"Ther. Drug Monit."},{"issue":"December","key":"10.1016\/j.jpba.2019.04.031_bib0070","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.forsciint.2017.11.004","article-title":"Role of hair pigmentation in drug incorporation into hair","volume":"281","author":"Yu","year":"2017","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.jpba.2019.04.031_bib0075","unstructured":"Summary of Product Characteristics Erlotinib. Food and Drug Administration[Internet]. [cited 2018 Aug 30]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2010\/021743s14s16lbl.pdf."},{"issue":"March (3)","key":"10.1016\/j.jpba.2019.04.031_bib0080","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S1470-2045(11)70393-X","article-title":"Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial","volume":"3","author":"Rosell","year":"2012","journal-title":"Lancet Oncol."},{"issue":"December (6)","key":"10.1016\/j.jpba.2019.04.031_bib0085","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/FTD.0000000000000552","article-title":"Effects of proton pump inhibitor co-administration on the plasma concentration of erlotinib in patients with non-small cell lung cancer","volume":"40","author":"Ohgami","year":"2018","journal-title":"Ther. Drug Monit."},{"issue":"April (12)","key":"10.1016\/j.jpba.2019.04.031_bib0090","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1200\/JCO.2015.65.2560","article-title":"Influence of the acidic beverage cola on the absorption of erlotinib in patients with non-samall-cell lung cancer","volume":"34","author":"van Leeuwen","year":"2016","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"issue":"May (5)","key":"10.1016\/j.jpba.2019.04.031_bib0095","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/nrclinonc.2014.40","article-title":"Determining the optimal dose in the development of anticancer agents","volume":"11","author":"Mathijssen","year":"2014","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"October (4)","key":"10.1016\/j.jpba.2019.04.031_bib0100","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/bcpt.12801","article-title":"Role of cytochrome P450 3A4 and 1A2 phenotyping in patients with advanced non-small-cell lung cancer receiving erlotinib treatment","volume":"121","author":"Parra-Guillen","year":"2017","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"January (1)","key":"10.1016\/j.jpba.2019.04.031_bib0105","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00228-007-0396-z","article-title":"The effects of CYP3A4 inhibition on erlotinib pharmacokinetics: computer-based simulation (SimCYP) predicts in vivo metabolic inhibition","volume":"64","author":"Rakhit","year":"2008","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"Febuary (1)","key":"10.1016\/j.jpba.2019.04.031_bib0110","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/FTD.0000000000000097","article-title":"Erlotinib: another candidate for the therapeutic drug monitoring of targeted therapy of cancer? A pharmacokinetic and pharmacodynamic systematic review of literature","volume":"37","author":"Petit-Jean","year":"2015","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.jpba.2019.04.031_bib0115","unstructured":"Humans IWG on the E of CR to. Solar and ultraviolet radiation [Internet]. International Agency for Research on Cancer; 2012 [cited 2019 Mar 20]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK304366\/."},{"issue":"Febuary (1)","key":"10.1016\/j.jpba.2019.04.031_bib0120","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/00007691-200102000-00004","article-title":"Relation between dosage of carbamazepine and concentration in hair and plasma samples from a compliant inpatient epileptic population","volume":"23","author":"Williams","year":"2001","journal-title":"Ther. Drug Monit."},{"issue":"October (6)","key":"10.1016\/j.jpba.2019.04.031_bib0125","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1093\/jat\/22.6.406","article-title":"The incorporation of drugs into hair: relationship of hair color and melanin concentration to phencyclidine incorporation","volume":"22","author":"Slawson","year":"1998","journal-title":"J. Anal. Toxicol."},{"issue":"October (4)","key":"10.1016\/j.jpba.2019.04.031_bib0130","doi-asserted-by":"crossref","first-page":"M1","DOI":"10.1530\/EJE-15-0313","article-title":"Clinical applications of cortisol measurements in hair","volume":"173","author":"Wester","year":"2015","journal-title":"Eur. J. Endocrinol."},{"issue":"October","key":"10.1016\/j.jpba.2019.04.031_bib0135","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.psyneuen.2015.06.011","article-title":"Determinants of hair cortisol and hair cortisone concentrations in adults","volume":"60","author":"Staufenbiel","year":"2015","journal-title":"Psychoneuroendocrinology."},{"issue":"Febuary (2)","key":"10.1016\/j.jpba.2019.04.031_bib0140","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/PL00007707","article-title":"Effect of the shampoo Ultra Clean on drug concentrations in human hair","volume":"113","author":"R\u00f6hrich","year":"2000","journal-title":"Int. J. Legal Med."},{"key":"10.1016\/j.jpba.2019.04.031_bib0145","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.psyneuen.2016.07.221","article-title":"In vitro influence of light radiation on hair steroid concentrations","volume":"73","author":"Grass","year":"2016","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.jpba.2019.04.031_bib0150","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.psyneuen.2016.06.016","article-title":"Hair cortisol and cortisone are decreased by natural sunlight","volume":"72","author":"Wester","year":"2016","journal-title":"Psychoneuroendocrinology"}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708519302894?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708519302894?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T08:56:13Z","timestamp":1760000173000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708519302894"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":30,"alternative-id":["S0731708519302894"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2019.04.031","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantification of the tyrosine kinase inhibitor erlotinib in human scalp hair by liquid chromatography-tandem mass spectrometry: Pitfalls for clinical application","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2019.04.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}